In 10 seconds? Scientists have used CRISPR/Cas9 gene-editing technology and nanoparticles to make cancer cells sensitive to a therapy that shrunk liver cancer in test animals. What did they do? They’ve combined the gene-editing t...
Dr. Abdulaziz Aldayel
Ph.D in Pharmaceutical Sciences, University of Texas. Specialises in RNA-therapies, lipid and polymeric nanonparticles, mAbs formulation, vaccine development